Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SyB D-0701 for Radiotherapy Induced Nausea and Vomiting
NCT01700140Phase 2Completed
- Sponsor
- SymBio Pharmaceuticals
- Start
- May 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Granisetron Hydrochloride Nasal Spray in radiotherapy-induced nausea and vomiting (RINV), sponsored by SymBio Pharmaceuticals. Started May 2011; status: completed.
02
Drugs
Granisetron Hydrochloride Nasal Spray
03
Conditions
radiotherapy-induced nausea and vomiting (RINV)
Beyond the preview
Go deeper on NCT01700140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01700140.